Rhythm Pharmaceuticals Shares See Volume; Traders Circulate M&A Rumors At $150/Share
The headline says Rhythm Pharmaceuticals shares saw volume as traders circulated an M&A rumor at $150 per share. The excerpt provides no further details or confirmation.
Why it matters — RYTM watchers may note the reported trading activity and unconfirmed acquisition speculation.